Literature DB >> 23234327

Cancer prevention and treatment using combination therapy with plant- and animal-derived compounds.

Jacinta Uzoigwe1, Edward R Sauter.   

Abstract

Compounds naturally occurring in plants and animals play an essential role in the prevention and treatment of various cancers. There are more than 100 plant- and animal-based natural compounds currently in clinical use. Similar to synthetic compounds, these natural compounds are associated with dose-related toxicity that limits efficacy. Scientists have investigated combination therapy with compounds that have different toxicities in order to optimize efficacy. These combination therapies may work additively or synergistically, there may be no effect or they may promote tumor formation. Combination therapy with agents that have similar mechanisms of action may increase toxicity. In this article, combination therapies that have been investigated, their rationale, mechanism of action and findings are reviewed. When the data warrant it, combined (pharmacologic and natural; two or more natural) interventions that appear to increase efficacy (compared with monotherapy) while minimizing toxicity have been highlighted.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23234327     DOI: 10.1586/ecp.12.62

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  10 in total

1.  Ursolic Acid Enhances the Sensitivity of MCF-7 and MDA-MB-231 Cells to Epirubicin by Modulating the Autophagy Pathway.

Authors:  Zhennan Wang; Pingping Zhang; Huan Jiang; Bing Sun; Huaizhi Luo; Aiqun Jia
Journal:  Molecules       Date:  2022-05-25       Impact factor: 4.927

Review 2.  Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions.

Authors:  Mohamed Ben-Eltriki; Subrata Deb; Emma S Tomlinson Guns
Journal:  J Cancer       Date:  2016-01-15       Impact factor: 4.207

3.  Genipin suppresses colorectal cancer cells by inhibiting the Sonic Hedgehog pathway.

Authors:  Bo Ram Kim; Yoon A Jeong; Yoo Jin Na; Seong Hye Park; Min Jee Jo; Jung Lim Kim; Soyeon Jeong; Suk-Young Lee; Hong Jun Kim; Sang Cheul Oh; Dae-Hee Lee
Journal:  Oncotarget       Date:  2017-10-16

4.  Pectolinarigenin Induced Cell Cycle Arrest, Autophagy, and Apoptosis in Gastric Cancer Cell via PI3K/AKT/mTOR Signaling Pathway.

Authors:  Ho Jeong Lee; Venu Venkatarame Gowda Saralamma; Seong Min Kim; Sang Eun Ha; Suchismita Raha; Won Sup Lee; Eun Hee Kim; Sang Joon Lee; Jeong Doo Heo; Gon Sup Kim
Journal:  Nutrients       Date:  2018-08-08       Impact factor: 5.717

5.  Auranofin and ICG-001 Emerge Synergistic Anti-tumor Effect on Canine Breast Cancer by Inducing Apoptosis via Mitochondrial Pathway.

Authors:  Zhaoyan Lin; Zixiang Lin; Ying Zhao; Nan Cheng; Di Zhang; Jiahao Lin; Hong Zhang; Degui Lin
Journal:  Front Vet Sci       Date:  2021-12-15

Review 6.  Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma.

Authors:  Divya Jain; Yogesh Murti; Wasi Ullah Khan; Rajib Hossain; Mohammad Nabil Hossain; Krishn Kumar Agrawal; Rana Azeem Ashraf; Muhammad Torequl Islam; Pracheta Janmeda; Yasaman Taheri; Mohammed M Alshehri; Sevgi Durna Daştan; Balakyz Yeskaliyeva; Aliya Kipchakbayeva; Javad Sharifi-Rad; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-10-31       Impact factor: 6.543

7.  Hesperetin inhibits Eca-109 cell proliferation and invasion by suppressing the PI3K/AKT signaling pathway and synergistically enhances the anti-tumor effect of 5-fluorouracil on esophageal cancer in vitro and in vivo.

Authors:  Dandan Wu; Jiao Li; Xue Hu; Jingjing Ma; Weiguo Dong
Journal:  RSC Adv       Date:  2018-07-06       Impact factor: 4.036

8.  The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM.

Authors:  Virginie Follin-Arbelet; Kristine Misund; Elin Hallan Naderi; Hege Ugland; Anders Sundan; Heidi Kiil Blomhoff
Journal:  Sci Rep       Date:  2015-08-26       Impact factor: 4.379

Review 9.  Targeted therapy for breast cancer prevention.

Authors:  Petra den Hollander; Michelle I Savage; Powel H Brown
Journal:  Front Oncol       Date:  2013-09-23       Impact factor: 6.244

Review 10.  Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer.

Authors:  Beate C Litzenburger; Powel H Brown
Journal:  Curr Breast Cancer Rep       Date:  2014
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.